When a biotech or biopharma’s flagship asset is ready for out-licensing, which strategies will get it noticed by the right partners?| Evaluate
Kelly's an expert in supporting competitive intelligence workflows & ensuring CI teams maximise the value of market intelligence for stakeholders.| Evaluate